Reiley Pharmaceuticals, Inc. — Form D

Reiley Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-07. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2017-11-07
• Form: D
• Accession: 0001616308-17-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.2M
• Amount sold: $1.2M
• Minimum investment: $13K
• Investors: 19
• Date of first sale: 2017-11-06
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-298211

Issuer

• Name: Reiley Pharmaceuticals, Inc.
• CIK: 0001616308
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 3749 BUCHANAN STREET, SAN FRANCISCO, CA, 94147
• Phone: 650 269-8044

Officers, directors & promoters (9)

Other filings by this issuer (7)

More

• CIK 1616308 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search